Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin directly affects mouse hair follicles and may influence hair growth.

Sudden, unusual hair loss may indicate serious underlying health issues.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

A woman's temporary hair loss after face lift surgery stopped on its own, and hair grew back.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Many people with hair loss experience scalp pain known as trichodynia, but the causes are unclear and treatments vary.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Adalimumab may cause severe hair loss in some patients.

Hair color is not a risk factor for developing alopecia areata.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

A woman's rare hair loss condition improved on its own, suggesting this type might recover like common cases.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Hair loss can cause serious mental health problems and treating it requires a team of experts.

Triangular temporal alopecia is a benign hair loss pattern best diagnosed with dermoscopy, with limited treatment options like surgery and hair transplantation.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

Hair follicle regeneration needs special conditions and young cells.

Hair follicle stem cells are a promising source for tissue repair and treating skin or hair diseases.